BI 409306 for Cognitive Impairment Due to Alzheimer's Disease

Language
Undefined

Purpose: To test the experimental drug BI 409306 in people with cognitive impairment due to Alzheimer's disease.

Source: Alzheimers Clinical Trials - October 19, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials